| Revenue growth | Value |
|---|---|
| 3Y CAGR | +593% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -67% |
| 3Y CAGR | -86% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,520.30 +17.80 (0.71%) | 19,162.17 | 28.26 | 5.69 | ||
PfizerPFIZER | ₹3,893.30 -24.60 (0.63%) | 17,811.42 | 20.73 | 4.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,507.00 -7.50 (0.12%) | 16,277.75 | 91.59 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹808.95 +4.60 (0.57%) | 15,862.14 | 13.86 | 1.51 |